Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar DDD in China

Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)

NCT07160205 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis

NCT01813617 ·Status: COMPLETED

Investigating Genes in Patients With Polymyositis and Dermatomyositis

NCT01171573 ·Status: ACTIVE_NOT_RECRUITING

Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS)

NCT01420432 ·Status: UNKNOWN ·Phase: PHASE1

Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis

NCT00802815 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.

NCT05211986 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory Myopathy

NCT04062019 ·Status: UNKNOWN ·Phase: PHASE2

Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis

NCT04976140 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immune Abnormalities in Sporadic Inclusion Body Myositis

NCT00030212 ·Status: COMPLETED

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

NCT05895786 ·Status: RECRUITING ·Phase: PHASE3

Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis

NCT03710941 ·Status: WITHDRAWN ·Phase: PHASE2

Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to Corticosteroids Intrabursal Injection

NCT01652495 ·Status: COMPLETED ·Phase: PHASE4

Low-dose Interleukin-2 in Combination With Standard Therapy on Idiopathic Inflammatory Myopathy

NCT04237987 ·Status: UNKNOWN ·Phase: PHASE2

Deflazacort in Dysferlinopathies

NCT00527228 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

NCT05523167 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

NCT05721573 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Alemtuzumab to Treat Sporadic Inclusion Body Myositis

NCT00079768 ·Status: COMPLETED ·Phase: PHASE2

Zanuburutinib in Relapsed and Refractory iMCD: a Prospective, Single-center, Single-arm Trial

NCT04743687 ·Status: UNKNOWN ·Phase: PHASE2

ASP 8825 - Study in Patients With Painful Diabetic Polyneuropathy

NCT00508430 ·Status: TERMINATED ·Phase: PHASE2

A Phase I Safety Study of NVG-291 in Healthy Adults

NCT05308953 ·Status: COMPLETED ·Phase: PHASE1

Phase III Trial of Sirolimus in IBM

NCT04789070 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis

NCT07122648 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China

NCT04535843 ·Status: RECRUITING

The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy

NCT01727193 ·Status: COMPLETED ·Phase: PHASE3

Molecular Profile of the Evolution of Inclusion Body Myositis

NCT03299335 ·Status: COMPLETED ·Phase: NA